Tackling Alzheimer’s by boosting mitochondrial health

canva photo editor

Alzheimer’s disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called beta-amyloid inside neurons.

Johan Auwerx’s lab at EPFL looked at mitochondria, which are the energy-producing powerhouses of cells, and thus central in metabolism. Using worms and mice as models, they discovered that boosting mitochondria defends against a particular form of protein stress, enables them to not only protect themselves, but to also reduce the formation of amyloid plaques.

The scientists identified two mechanisms that control the quality of mitochondria: First, the “mitochondrial unfolded protein response” (UPRmt), which protects mitochondria from stress stimuli. Second, mitophagy, a process that recycles defective mitochondria. Both these mechanisms are the key to delaying or preventing excessive mitochondrial damage during disease.

[T]ackling Alzheimer’s through mitochondria could make all the difference. “So far, Alzheimer’s disease has been considered to be mostly the consequence of the accumulation of amyloid plaques in the brain,” he says. “We have shown that restoring mitochondrial health reduces plaque formation – but, above all, it also improves brain function, which is the ultimate objective of all Alzheimer’s researchers and patients.”

[The original study can be found here (behind paywall)]

Read full, original post: Healthy Mitochondria Could Stop Alzheimer’s

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Aug-4-2026-10_15_14-AM
Viewpoint—A hard look at the Fauci diaries: Do they change what we know about COVID’s origins?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Aug-4-2026-12_42_58-PM
Viewpoint: Fact-checking CNN interview with RFK, Jr. underscores the depth of his disinformation delusions
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Jul-17-2026-09_50_27-AM
Viewpoint: How disease tracking and prevention has cratered under the Kennedy-Trump administration
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT-Image-Aug-4-2026-07_52_00-PM
No liability for scientific due diligence: California Supreme Court rejects bizarre lawsuit faulting Gilead for fully evaluating HIV drug before release
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
ChatGPT-Image-Aug-4-2026-09_31_50-AM-2
Viewpoint: Could the U.S. become dependent on China to develop critical new genetic and drug therapies?
ChatGPT-Image-Aug-4-2026-02_05_46-PM
Does Congress have the guts to successfully challenge Trump’s politicization of science funding?
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.